|
gptkbp:instanceOf
|
gptkb:clinical_trial
|
|
gptkbp:ageRange
|
18 years and older
|
|
gptkbp:allocates
|
Randomized
|
|
gptkbp:clinicalTrialsGovURL
|
https://clinicaltrials.gov/ct2/show/NCT04505722
|
|
gptkbp:completedIn
|
2022-10-27
|
|
gptkbp:condition
|
gptkb:COVID-19
|
|
gptkbp:enrollment
|
30420
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
NCT04505722
|
|
gptkbp:intervention
|
gptkb:mRNA-1273
|
|
gptkbp:location
|
gptkb:United_States
|
|
gptkbp:mask
|
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
|
|
gptkbp:otherName
|
COVE Study
|
|
gptkbp:period
|
Phase 3
|
|
gptkbp:primaryCompletionDate
|
2022-02-25
|
|
gptkbp:principalInvestigator
|
Lindsey R. Baden, MD
|
|
gptkbp:result
|
Efficacy of mRNA-1273 to prevent COVID-19
|
|
gptkbp:sponsor
|
gptkb:ModernaTX,_Inc.
|
|
gptkbp:startDate
|
2020-07-27
|
|
gptkbp:status
|
Completed
|
|
gptkbp:studyType
|
Interventional
|
|
gptkbp:title
|
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older
|
|
gptkbp:bfsParent
|
gptkb:ENSEMBLE_trial
|
|
gptkbp:bfsLayer
|
7
|